Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2025, 7(1); doi: 10.25236/IJFM.2025.070114.

Clinical Study of Naoxintong Combined with Aspirin in the Treatment of Senile Ischemic Cerebrovascular Disease

Author(s)

Li Zhilian, Jiang Dajing

Corresponding Author:
Jiang Dajing
Affiliation(s)

Jingzhou First People's Hospital, Jingzhou, 434020, Hubei, China

Abstract

In this study, 68 elderly patients with ischemic cerebrovascular disease (ICD) were randomly selected from June 2023 to June 2024, and were divided into group A (34 cases, conventional treatment + aspirin) and group B (34 cases, combined with Naoxintong on the basis of group A) by double-blind method, and the therapeutic effects of the two groups were compared. After treatment, the hemorheological indexes and NIHSS scores in group B were lower than those in group A (P < 0.05), the effective rate in group B was higher than that in group A (P < 0.05), and the incidence of adverse reactions in group B was higher than that in group A (P > 0.05). ICD patients treated with Naoxintong and aspirin can better improve hemorheology and neurological function, and the effect is significant and safe.

Keywords

Naoxintong; Aspirin; Senile; Ischemic cerebrovascular disease; Curative effect

Cite This Paper

Li Zhilian, Jiang Dajing. Clinical Study of Naoxintong Combined with Aspirin in the Treatment of Senile Ischemic Cerebrovascular Disease. International Journal of Frontiers in Medicine (2025), Vol. 7, Issue 1: 86-90. https://doi.org/10.25236/IJFM.2025.070114.

References

[1] Tian Tian, Lv Hongxiang. Clinical effect of aspirin combined with clopidogrel in the treatment of acute ischemic cerebrovascular disease [J]. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2023, 11 (27): 38-41.

[2] Guo Qiangrui, Zhang Shiqi, Mao Zeyu, et al.Clinical efficacy of ginkgo biloba extract combined with aspirin in elderly patients with ischemic cerebrovascular disease caused by cerebral embolism diagnosed by CT [J].Chinese Journal of Gerontology, 2023,43 (14): 3347-3350.

[3] Xu Wei. Effect of clopidogrel combined with aspirin on ischemic cerebrovascular disease and its influence on plasma P-selectin [J]. Journal of Clinical Rational Drug Use, 2022, 15 (7): 8-10.

[4] Zhao Liqin. Effect of Naoxintong combined with aspirin on senile ischemic cerebrovascular disease [J]. Clinical Journal of Integrated Traditional Chinese and Western Medicine, 2021, 21 (18): 102-103.

[5] Zhang Meiying, Ma Wenqun, Zhang Jinxia.Effect of cerebroprotein hydrolysate combined with Naoxintong capsule on plasma BNDF, NSE and S100β expression in patients with ischemic cerebrovascular disease [J].Journal of Clinical and Experimental Medicine, 2021, 20 (14): 1470-1473.

[6] Chen Pian-pian. Effect of Xuesaitong combined with aspirin on ischemic cerebrovascular disease and blood pressure control rate [J]. World Latest Medical Information Digest, 2019, 19 (21): 12-13.

[7] Yang Yun. Effect of Xuesaitong combined with aspirin on ischemic cerebrovascular disease and blood pressure control rate [J]. Chinese Medical Guide, 2020, 18 (12): 191-192.

[8] Sun Zhijun, Wang Honglin, Wang Huifen, et al. Clinical observation of Naoxintong combined with aspirin in the treatment of senile ischemic cerebrovascular disease [J]. Renren Health, 2020, 1 (3): 204.

[9] Lin Dan. Clinical efficacy analysis of Naoxintong combined with aspirin in the treatment of senile ischemic cerebrovascular disease [J]. Cardiovascular Disease Prevention and Treatment Knowledge, 2020, 10 (25): 15-17.

[10] Zhang Ziyan. Study on the efficacy of Xuesaitong combined with aspirin in the treatment of ischemic cerebrovascular disease [J]. Psychological Journal, 2019, 14 (12): 198.

[11] Li Li. Study on the application of Naoxintong combined with aspirin in elderly patients with ischemic cerebrovascular disease [J]. Medical Dietotherapy and Health, 2021, 19 (4): 92-93.

[12] Deng Tengwei, Li Hong. Clinical efficacy of Naoxintong combined with aspirin in the treatment of senile ischemic cerebrovascular disease [J]. Journal of Clinical Rational Drug Use, 2019, 12 (3): 53-55.